First commercial implantation of ReActiv8 in Ireland takes place

232
Mainstay Medical’s ReActiv8

The first Irish sale and implantation of Mainstay Medical’s ReActiv8 has taken place in Dublin. The implantation was performed at St Joseph’s Hospital, part of the Beaumont Hospital Group, in Dublin, by Josh Keaveny and Alexander Moudrakovski, consultants in anaesthesia and pain medicine.

Keaveny comments, “ReActiv8 represents a novel approach to chronic low back pain which addresses the underlying cause of the condition. We now have a new option for treating patients who have suffered from debilitating back pain for years who are not candidates for spine surgery and have attempted many other conventional therapies without adequate relief.”

ReActiv8 works by electrically stimulating the nerves responsible for contracting the key stabilising muscles of the lumbar spine. Activation of these muscles to restore functional spine stability has been shown to facilitate recovery from chronic low back pain.

Mainstay received CE mark for ReActiv8 supported by positive results from the ReActiv8-A clinical trial that demonstrated a clinically important, statistically significant and lasting improvement in pain, disability and quality of life in people with disabling chronic low back pain and few other treatment options.

(Visited 66 times, 1 visits today)